SELLAS Life Sciences (SLS) Assets (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Assets for 9 consecutive years, with $26.5 million as the latest value for Q3 2024.
- On a quarterly basis, Assets changed N/A to $26.5 million in Q3 2024 year-over-year; TTM through Sep 2024 was $26.5 million, a N/A change, with the full-year FY2023 number at $6.2 million, down 70.31% from a year prior.
- Assets was $26.5 million for Q3 2024 at SELLAS Life Sciences, up from $15.1 million in the prior quarter.
- In the past five years, Assets ranged from a high of $46.0 million in Q4 2020 to a low of $6.2 million in Q4 2023.
- A 5-year average of $26.8 million and a median of $26.0 million in 2022 define the central range for Assets.
- Peak YoY movement for Assets: soared 177.25% in 2020, then crashed 70.31% in 2023.
- SELLAS Life Sciences' Assets stood at $46.0 million in 2020, then crashed by 42.94% to $26.3 million in 2021, then fell by 20.29% to $20.9 million in 2022, then plummeted by 70.31% to $6.2 million in 2023, then soared by 326.19% to $26.5 million in 2024.
- Per Business Quant, the three most recent readings for SLS's Assets are $26.5 million (Q3 2024), $15.1 million (Q2 2024), and $6.2 million (Q4 2023).